{
  "type": "hyp",
  "text": "The inhibition correlated with a decrease in steady state levels of E-selectin mRNA and cell surface expression of E-selectin which is consistent with the ability of a monoclonal antibody to E-selectin to inhibit monocyte adhesion in this system.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "The inhibition",
        "a decrease",
        "steady state levels",
        "E-selectin mRNA and cell surface expression",
        "E-selectin",
        "the ability",
        "a monoclonal antibody",
        "E-selectin",
        "monocyte adhesion",
        "this system"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was associated with a decrease in steady state levels of E-selectin",
          "What was the effect of the inhibition on steady state levels of E-selectin",
          "What did the inhibition of E-selectin mRNA and cell surface expression of",
          "What did the inhibition of a cytokine receptor decrease?",
          "What protein was inhibited by a monoclonal antibody?",
          "What is the ability of a monoclonal antibody to inhibit monocyte adhesion",
          "What is consistent with the ability of E-selectin to inhibit monocyte adhe",
          "What protein was inhibited by a monoclonal antibody?",
          "What did the inhibition of E-selectin inhibit?",
          "What system does a monoclonal antibody to E-selectin inhibit?"
        ]
      }
    }
  },
  "asked": {
    "What is the reason for the adiponectin being able to inhibit monocyte": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.19753867387771606,
        "ground_truth": {
          "We": {
            "bertscore": 0.6054112315177917,
            "f1": 0
          }
        }
      }
    },
    "What do we propose may contribute to some of the antiatherogenic properties of NOs?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0007278323173522949,
        "ground_truth": {
          "that NOs ability": {
            "bertscore": 0.663084089756012,
            "f1": 0
          }
        }
      }
    },
    "What does NO limit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00013363361358642578,
        "ground_truth": {
          "endothelial activation": {
            "bertscore": 0.626808762550354,
            "f1": 0
          }
        }
      }
    },
    "What does NO inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0005781650543212891,
        "ground_truth": {
          "monocyte adhesion": {
            "bertscore": 0.6535466313362122,
            "f1": 0
          }
        }
      }
    },
    "What properties of NOs are thought to be a contributing factor to the formation of a": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0005647540092468262,
        "ground_truth": {
          "its antiatherogenic and antiinflammatory properties": {
            "bertscore": 0.5509083867073059,
            "f1": 0
          }
        }
      }
    },
    "What part of the body does NO have antiatherogenic properties?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00024515390396118164,
        "ground_truth": {
          "the vessel wall": {
            "bertscore": 0.6866961121559143,
            "f1": 0
          }
        }
      }
    }
  }
}